Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580528 · ClinicalTrials.gov registry record · NA
Reducing Blood Pressure in Prehypertensive Older Rural Women Also Known as Wellness for Women: DASHing Toward Health
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 289
- Enrollment target
NCT00580528: Completed NA study, sponsored by University of Nebraska.
NCT00580528 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 289 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580528, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 289 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a theory-based intervention tailored to constructs in the Health Promotion Model and delivered by two distance modes to achieve improvement in healthy eating and physical activity for the control of blood pressure (BP) among an underserved and vulnerable population of prehypertensive rural women aged 50 to 69.
Primary Outcome
Blood pressure with the criterion of normotensive status
Interventions
- BEHAVIORAL Tailored Internet Newsletters
- BEHAVIORAL Tailored print newsletters delivered via mail
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2006-08-01 |
| Est. Completion | 2011-05-01 |
| Phase | NA |
What the finished NCT00580528 record still lists
NCT00580528 is an interventional study that assigns participants to a tested intervention. The registered 289 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which Tailored Internet Newsletters is the first listed.
NCT00580528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00580528 about?
NCT00580528 is a clinical study titled "Reducing Blood Pressure in Prehypertensive Older Rural Women Also Known as Wellness for Women: DASHing Toward Health". The purpose of this study is to evaluate the effectiveness of a theory-based intervention tailored to constructs in the Health Promotion Model and delivered by two distance modes to achieve improvement in healthy eating and physical activity for the control of blood pressure (BP) among an underserve...
What is the current status of trial NCT00580528?
This trial is currently completed. It is a NA study. The enrollment target is 289 participants. The study started on 2006-08-01. Estimated completion is 2011-05-01.
What interventions are being tested in trial NCT00580528?
The interventions under investigation include: Tailored Internet Newsletters (BEHAVIORAL), Tailored print newsletters delivered via mail (BEHAVIORAL).
Who is sponsoring clinical trial NCT00580528?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00580528's enrollment target sits among peer trials
289 376th of 2000 higher than 1,625 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465199 · 289 participants · Phase 1
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- NCT00775476 · 290 participants · Phase 2
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine
- NCT01874197 · 290 participants · NA
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
- NCT04331353 · 290 participants · NA
The Allergen Reduction and Child Health Study (ARCHS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI